@FierceBiotech: COMMENTARY: Why would Martin Shkreli hike an old drug price by 5000%? Only a 'moron' would ask. More | Follow @FierceBiotech
@JohnCFierce: One win, one loss in Merck's PhIII double header for C diff. Story | Follow @JohnCFierce
@DamianFierce: Filed under Roche Hubris Watch: Reuters article | Follow @DamianFierce
> ANI Pharmaceuticals ($ANIP) paid Merck ($MRK) $75 million for a pair of approved but little-used drugs, planning to relaunch them and compete with Mallinckrodt Pharmaceuticals' ($MNK) Acthar gel. More
> Aerie Pharmaceuticals ($AERI) has kicked off a Phase III trial of Roclatan, its in-development eye drop for glaucoma and ocular hypertension. News
> Boehringer Ingelheim is teaming up with Germany's BioMed X Innovation Center in hopes of identifying the epigenetic regulators of COPD. Item
Medical Device News
@FierceMedDev: ICYMI: Upstart Establishment gets $20M+ to bring safer breast implants with nanotech, RFID tracking to U.S. Article | Follow @FierceMedDev
@StacyALawrence: ICYMI last week: Google hires top government brain scientist to probe mental illness. Story | Follow @StacyALawrence
@EmilyWFierce: Some light reading on Otsuka and Proteus' antipsychotic with a built-in sensor. Wired story | Follow @EmilyWFierce
> The NBA's studying wearable monitors. Will players soon wear them during games? More
> CMS proposal to restrict coverage of artificial limbs facing pushback from amputees. Article
Pharma News
@FiercePharma: Consumer ranking of fast-food chains' antibiotics in meat calls out FDA, industry for change. FierceAnimalHealth report | Follow @FiercePharma
@EricPFierce: ICYMI from FiercePharmaManufacturing: Ireland pharma biz going to the dogs, so to speak. Nextvet picks up biologics plant there. Item | Follow @EricPFierce
@CarlyHFierce: Watch out, Afinitor. Bristol's 'breakthrough' Opdivo is coming for you. More from FiercePharmaMarketing | Follow @CarlyHFierce
> Hillary Clinton to lay out her plan for cutting drug prices. Article
> Bloomberg: Sanofi, Pfizer mull potential deal for Mexican generics maker Rimsa. More
Animal Health News
> Science think tank calls for global phaseout of antibiotics in agriculture. More
> Merck pioneers injectable vaccine for common pig disease. Item
> VetStem launches trial of drug-free method for preventing hemorrhage in horses. Story
> Consumer ranking of fast-food chains' antibiotics in meat calls out FDA, industry for change. Article
> ViroVet spins out of Aratana with focus on livestock health. Report
Biotech IT News
> Traders pay SEC $30M to settle newswire hacking case. More
> Google lures NIH mental health chief to life sciences team. News
> Harvard connection helps WuXi NextCODE land Chinese hospital contract. Report
> Microsoft lands cloud genomics infrastructure deal with UC Santa Cruz. Article
> Number of clinical trials to use wearables nears 300. Story
Pharma Marketing News
> More followers and more daily tweeting as Big Pharma's Twitter presence grows. Story
> Sanofi, Pfizer said to be among suitors for Mexico's Rimsa. Item
> Janssen's latest Prezcobix effort taps HIV activists to curate patient-story contest. More
> For sale: Orange paint. It might just become your brand's signature. Editor's Corner
> Watch out, Afinitor. Bristol's 'breakthrough' Opdivo is coming for you. Article